Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Chopas James George reported 13 trades in Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, Chopas James George (VP/Chief Accounting Officer) reported 13 trades in Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Shares
- 65,955 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- VP/Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 65,955 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 5,625 | 5,625 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 5,625 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 8,394 | 8,394 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 8,394 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 16,150 | 16,150 | Direct | |
| May 14, 2026 | Common Stock | Award | 8,075 | 8,075 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 8,075 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 2,406 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 4,156 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 9,444 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 16,150 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 6,250 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Chopas James George
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026